Eterna Therapeutics
ERNA
#10313
Rank
โ‚น0.91 B
Marketcap
โ‚น116.54
Share price
3.33%
Change (1 day)
-66.21%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): -โ‚น6,436

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น6,867. In 2022 the company made an earnings per share (EPS) of -โ‚น11,266 an increase over its 2021 EPS that were of -โ‚น74,429.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น6,436
2022-โ‚น11,266-84.86%
2021-โ‚น74,429

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Baxter
BAX
-โ‚น59.08-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น10.74-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-โ‚น180.82-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น331.72-104.83%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Techne
TECH
โ‚น44.76-100.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น56.40-100.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel